Will Date
Greenhalgh legacy set to continue at CX 2024
Though the 2024 edition of the Charing Cross (CX) International Symposium (April 23–25) in London, England, marks a new era, it will be tinged...
EACTS and STS guidelines recognize aorta ‘as an organ in its...
New guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the Society of Thoracic Surgeons (STS) have, for the first time, recognized the...
FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial.
The study will...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk...
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD)...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
Multicenter study points to favourable safety and efficacy of radial access...
New research examining the safety and efficacy of using radial access for peripheral artery interventions has found that radial access allows early ambulation and...
Long-awaited FDA update finds data do not support excess mortality risk...
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
VAM 2023 attendees have their say on the impact of BEST-CLI...
As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
‘Excellent’ limb salvage rates for trauma bypass performed by vascular surgeons
Revascularization for extremity trauma can be performed with excellent limb salvage rates, though poor compliance with long-term surveillance raises some cause for concern.
These...
Generational divide: Do baby boomers and millennials see eye-to-eye on vascular...
Older-generation vascular surgeons are keen to hone their endovascular skills, while the younger generation are looking to develop their capacity to treat aortic pathologies—but...
Risk assessment models “no better than coin toss” for predicting bleeding...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
VAM 2023: Vascular trauma session to highlight the current role of...
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field.
Moderated by Sherene Shalhub, MD, of...
Prediction model offers new option for forecasting AAA growth
A predictive model incorporating 3D shape features such as aneurysmal flow lumen and outer wall structure extracted from computed tomography (CT) imaging can improve...
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular...
Significant life and limb gains for claudicants who stop smoking before...
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
FDA seeks to ‘modernize’ clinical trials with new draft guidance
The Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and...
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical...
Efemoral Medical closes financing round to fund ongoing study of its...
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
CX Aortic Vienna: Onus on industry to meet clinician desire for...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to late...
CX Aortic Vienna: Cardiac, vascular surgeons collaborate at the vanguard of...
CX Aortic Vienna returns in October for its third edition (Oct. 24–26, Digital), bringing together world-leading specialists from the cardiac and vascular fields...
Artificial intelligence can predict risk of complications after endovascular aneurysm repair
Artificial intelligence (AI) models can be developed to predict the risk of postoperative complications after endovascular aneurysm repair (EVAR) with “high accuracy,” research presented...
Study of post-carotid endarterectomy surveillance prompts protocol discussion
The results of an analysis of nearly 2,000 carotid endarterectomies (CEAs) “challenge the notion” that patients benefit significantly from the current post-operative surveillance guidelines,...
Vascular surgeons ‘have a role to play’ in transcatheter aortic valve...
Vascular surgery assistance in transcatheter aortic valve replacement (TAVR) can facilitate safe and effective device introduction through cases involving challenging femoral or iliac access....
F/BEVAR has high technical success and low mortality in chronic post-dissection...
Fenestrated/branched endovascular aneurysm repair (F/BEVAR) is associated with high technical success and low mortality in patients with chronic post-dissection thoracoabdominal aortic aneurysm (PD-TAAA). This...
Low rate of new white lesions detected after TCAR using diffusion-weighted...
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularization (TCAR), a study in which patients were assessed...
‘Endovation’: Guidelines from the front lines
Among the highlights from the “‘Endovation’—Endovascular Innovation for Urgent and Emergency Complex Aortic Disorders” session coming up at the 2022 Vascular Annual Meeting (VAM)...
FDA grants IDE approval for Selution SLR drug-eluting balloon
MedAlliance’s Selution SLR drug-eluting balloon (DEB) has received investigational device exemption (IDE) approval from the Food and Drug Administration, making it the first limus...
Medtronic gains FDA nod for IN.PACT 018 DCB
Medtronic has announced approval from the Food and Drug Administration (FDA) for the IN.PACT 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter, a drug-coated...
Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at...
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes...
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official position statement providing evidence-based recommendations for percutaneous transaxillary arterial access and training...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Guidelines recognize potential role for earlier endovascular treatment of uncomplicated type...
New clinical practice guidelines published today aim to act as “guard rails” to determine the treatment options and best practices for managing patients with...
Research reveals improved outcomes, decreased mortality in management of aortic dissections...
The Minneapolis Heart Institute Foundation (MHIF) has announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissection patients...
IN.PACT Admiral DCB performs well across wide range of clinical, anatomical...
In a pooled analysis of the predictors of drug-coated balloon (DCB) effectiveness, the IN.PACT Admiral DCB (Medtronic) performed well across a broad range of clinical, anatomical...
Philips announces large-scale study outcomes on use of IVUS in peripheral...
Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...
Physicians, industry urged to tackle multifactorial stroke risk following thoracic endovascular...
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures,...
Analysis shows TCAR is more cost effective than CAS for carotid...
Transcarotid artery revascularization (TCAR) produces similar outcomes to the gold standard treatment for carotid stenosis—carotid endarterectomy (CEA)—but comes at a greater cost. This was...
Medical Device Regulation goes into effect across EU
The European Union (EU) Medical Device Regulation (MDR) takes effect from today (May 26).
The Regulation revises quality and safety standards and the range of...
ACC.21: SAFE-PAD finds no increased risk of death with drug-coated devices
Researchers have found no statistically significant difference in mortality between patients treated with drug-coated devices and non-drug-coated devices in the SAFE-PAD study. Eric Secemsky,...
ACC.21: VOYAGER PAD shows rivaroxaban ‘significantly’ reduced total ischemic events in...
Rivaroxaban combined with low-dose aspirin led to a significant reduction in the occurrence of total ischemic events in patients with symptomatic peripheral arterial disease...